Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Low Titer of Antibody Against Toxoplasma Gondii May Be Related to Resistant to Cancer Publisher Pubmed



Seyedeh M1 ; Shahrekord S2 ; Nahid M3 ; Shima D3 ; Morteza Y2 ; Hossein Y4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Studen. Research Committee, Shahrekord University of Medical Sciences, Shahrekord, Iran
  3. 3. Department of Parasitology and Mycology, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Cancer Prevention Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Cancer Research and Therapeutics Published:2015


Abstract

Context: Toxoplasma gondii is a protozoan parasite with a world-wide distribution. However, the majority of infected cases remain symptomless. There are raising scientific evidences indicating that parasitic infections induce antitumor activity against certain types of cancers. The inhibitory effect of T. gondii on cancer growth has also been shown in cell culture and mouse model. Aims: Considering the anti-tumor effect of this parasite, in this study the relationship between low titer of antibodies against T. gondii and resistant to cancers has been investigated. Subjects and Methods: In two separate experiments, anti T. gondii antibody was estimated in 150 patients with cancer and 120 normal people. Statistical Analysis Used: Chi-square test was used for data analysis. Results: The frequency of low titer antibody against Toxoplasma gondii in cancer patients was significantly higher than the frequency of low-titer antibody against this parasite in normal people. Conclusions: Exposure to T. gondii may be related to resistance to cancer.
Related Docs
View other Related Docs
1. Parasites and Cancers: Parasite Antigens As Possible Targets for Cancer Immunotherapy, Future Oncology (2012)
2. Parasites As Potential Targets for Cancer Immunotherapy, Journal of Cancer Research and Clinical Oncology (2023)
3. Anti-Toxoplasma Gondii Antibodies Attach to Mouse Cancer Cell Lines But Not Normal Mouse Lymphocytes, Biomedical Reports (2019)
4. Anti-Cancer Immunoprotective Effects of Immunization With Hydatid Cyst Wall Antigens in a Non-Immunogenic and Metastatic Triple-Negative Murine Mammary Carcinoma Model, International Immunopharmacology (2021)
5. Effects of Toxoplasma Gondii and Toxocara Canis Antigens on Wehi-164 Fibrosarcoma Growth in a Mouse Model, Korean Journal of Parasitology (2009)
6. Human Anti-Toxoplasma Antibodies Attach Strongly to Breast Cancer Cells, International Journal of Cancer Management (2023)
7. Mutual Action of Anticancer and Antiparasitic Drugs: Are There Any Shared Targets?, Future Oncology (2014)
8. Parasites and Immunotherapy: With or Against?, Journal of Parasitic Diseases (2016)
Experts (# of related papers)
View all Related Experts
Hossein Yousofi Darani (19)
Seyed Hossein Hejazi (11)
Other Related Docs
9. Effect of Hydatid Cyst Antigens Polyspecific Antisera on Breast Cancer Cells (4T1) Growth in Cell Culture Medium, International Journal of Environmental Health Engineering (2022)
10. Effect of Alive Protoscoleces of Hydatid Cyst on the Growth of Melanoma Cells in Mouse Model, Journal of Isfahan Medical School (2014)
11. Effect of Two Hydatid Cyst Antigens on the Growth of Melanoma Cancer in C57/Black Mice, Journal of Parasitic Diseases (2016)
12. A Systematic Review of Toxoplasma Gondii Antigens to Find the Best Vaccine Candidates for Immunization, Microbial Pathogenesis (2019)
13. Inhibition of Mouse Colon Cancer Growth Following Immunotherapy With a Fraction of Hydatid Cyst Fluid, Experimental Parasitology (2023)
14. Prevalence of Toxoplasma Infection in Veterinary Laboratory Sciences Students Comparing to Ordinary People: A Case–Control Study, Journal of Parasitic Diseases (2016)
15. Serological Evaluation of Anti-Toxoplasma Gondii Antibodies in Patients With Acute Leukemia and Lymphoma Through Chemotherapy, Iranian Journal of Parasitology (2020)
16. The Seroprevalence of Anti-Toxoplasma Gondii Igg and Igm Antibodies in Serum Samples Referred to Educational Hospitals of Abadan, Journal of Isfahan Medical School (2022)
17. Toxoplasmosis and Symptoms Severity in Patients With Covid-19 in Referral Centers in Northern Iran, Journal of Parasitic Diseases (2023)
18. Identifying the Most Effective Hydatid Cyst Fluid Fraction for Anticancer Vaccination of 4T1 Breast Tumor-Bearing Mice, International Journal of Preventive Medicine (2019)
19. Frequency of Sero-Positivity in Household Members of the Patients With Positive Toxoplasma Serology; [Frecuencia De Seropositividad En Los Miembros De Hogares De Pacientes Con Serologia Positiva Para Toxoplasma], Revista Espanola de Quimioterapia (2018)
20. Effect of Hydatid Cyst Antigens on Inhibition of Melanoma Cancer Growth in Mouse Model, Cellular and Molecular Biology (2018)
21. A Large-Scale Study on the Seroprevalence of Toxoplasma Gondii Infection in Humans in Iran, Folia Parasitologica (2023)
22. Prevalence of Anti-Toxoplasma Gondii Antibodies in Young Iranians: The Caspian Iii Study, Archives of Pediatric Infectious Diseases (2018)
23. High Occurrence of Toxoplasma Gondii Infection Among Blood Donors in Ardabil Province As Main Focus of Zoonotic Visceral Leishmaniosis, Northwestern Iran, Annals of Parasitology (2021)
24. The Gene Expression Level of Ifn-Γr1 and Ifn-Γr2 in a Murine Model Treated With Toxoplasma Gondii and Its Products, Gastroenterology and Hepatology from Bed to Bench (2016)
25. Detection of Toxoplasma Parasitemia by Pcr: Does It Correlate With Igg and Igm Antibody Titers?, Iranian Journal of Immunology (2006)
26. Evaluation of Toxoplasma Gondii Infection in Western Iran: Seroepidemiology and Risk Factors Analysis, Tropical Medicine and Health (2020)
27. Seroepidemiology of Toxoplasma Gondii Infection in Isfahan Province, Central Iran: A Population Based Study, Journal of Research in Medical Sciences (2011)
28. A Systematic Review on the Role of Gra Proteins of Toxoplasma Gondii in Host Immunization, Journal of Microbiological Methods (2019)
29. Toxoplasma Serology Status and Risk of Miscarriage, a Case-Control Study Among Women With a History of Spontaneous Abortion, International Journal of Fertility and Sterility (2019)
30. Cloning, Expression and Characterization of Toxoplasma Gondii P35 Protein in E. Coli, Yakhteh (2006)
31. Seroprevalence of Toxoplasmosis in Mentally Retarded Patients in Iranian Rehabilitation Centers, Journal of Parasitic Diseases (2015)
32. Monoclonal Antibodies Production Against a 40Kda Band of Hydatid Cyst Fluid, Recent Patents on Biotechnology (2018)
33. Evaluation of Antinuclear Antibodies in Pregnant Women With Abortion With Toxocariasis and Toxoplasmosis in Iran; [Iran’Da Toksokariyaz Ve Toksoplazmozlu Dusuk Yapan Gebelerde Antinukleer Antikorlarin Degerlendirilmesi], Turk Hijyen ve Deneysel Biyoloji Dergisi (2022)
34. Study of Serological Toxoplasmosis and Risk Factors Associated With Infection in Women Referred to Labs of Northern Tehran, Iran, Journal of Isfahan Medical School (2013)
35. Prevalence of Toxoplasma Gondii and the Level of Il8 in Patients With Celiac Disease, Koomesh (2016)
36. Seroprevalence of Toxoplasma Infection in Individuals Occupationally Exposed to Livestock and Raw Meat: A Case–Control Study, Veterinary Medicine and Science (2023)
37. Detection of Toxoplasma Gondi in Acute and Chronic Phases of Infection in Immunocompromised Patients and Pregnant Women With Real-Time Pcr Assay Using Taqman Fluorescent Probe, Iranian Journal of Parasitology (2018)
38. Evaluation of Th17 Immune Responses of Recombinant Dna Vaccine Encoding Gra14 and Rop13 Genes Against Toxoplasma Gondii in Balb/C Mice, Infection, Genetics and Evolution (2021)
39. Seroepidemiology of Toxoplasma Gondii Infection in Pregnant Women in West Iran: Determined by Elisa and Pcr Analysis, Journal of Parasitic Diseases (2017)
40. Prevalence of Toxoplasmosis and Related Risk Factors Among Humans Referred to Main Laboratories of Urmia City, North West of Iran, 2013, Journal of Parasitic Diseases (2016)
41. Knocking Down the Expression of the Molecular Motors, Myosin A, C and F Genes in Toxoplasma Gondii to Decrease the Parasite Virulence, Experimental Parasitology (2023)
42. The Probable Association Between Chronic Toxoplasma Gondii Infection and Type 1 and Type 2 Diabetes Mellitus: A Case-Control Study, Interdisciplinary Perspectives on Infectious Diseases (2021)
43. The Prevalence Rate of Infection to Toxoplasma Gondii in Domestic and Industrial Breeding Poultry in Isfahan City, Iran, 2020, Journal of Isfahan Medical School (2021)
44. Seroprevalence of Toxoplasma Gondii and Toxocara Spp. Infections Among Pregnant Women With and Without Previous Abortions in the West of Iran, Journal of Obstetrics and Gynaecology Research (2020)
45. Comparison of Eight Cell-Free Media for Maintenance of Toxoplasma Gondii Tachyzoites, Iranian Journal of Parasitology (2016)
46. Seroprevalence of Toxoplasmosis in Kermanshah City, West of Iran, Annals of Parasitology (2021)
47. Prevalence of Toxoplasma Gondii in Hiv-Infected Individuals in Iran: A Systematic Review and Meta-Analysis, Current HIV Research (2023)
48. Frequency of Blood-Tissue Parasitic Infections in Patients With Multiple Sclerosis, As Compared to Their Family Members, International Journal of Preventive Medicine (2014)
49. Toxoplasma Gondii Tyrosine-Rich Oocyst Wall Protein: A Closer Look Through an in Silico Prism, BioMed Research International (2021)
50. A Simple and Innovative Method for Cell Membrane Passing the Small Interfering Rna (Sirna) in Eukaryotic Cells; Toxoplasma Gondii As an Experience, Journal of Isfahan Medical School (2017)